Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-18T06:57:38.479Z Has data issue: false hasContentIssue false

Aripiprazole for autism spectrum disorders (ASD), a Cochrane Review

Published online by Cambridge University Press:  26 April 2023

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Cochrane corner
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

This review is the abstract of a Cochrane Review previously published in the Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD009043. DOI: 10.1002/14651858.CD009043.pub3.

(see www.cochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and Cochrane Database of Systematic Reviews should be consulted for the most recent version of the review.”

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

We thank the Cochrane Developmental, Psychosocial and Learning Problems Group for their support in publishing this review

Submit a response

eLetters

No eLetters have been published for this article.